Metastasis-Associated Protein S100A4 and p53 Predict Relapse in Curatively Resected Stage III and IV (M0) Gastric Cancer

REFERENCES

• Central Cancer Registry in Korea. Annual Report of the Central Cancer Registry in Korea. Ministry of Health and Welfare, Seoul 2002
   Google Scholar
• Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 1999; 80: 827–841
   PubMed Web of Science ®Google Scholar
• Peeters K. C., van de Velde C. J. Improving treatment outcome for gastric cancer: The role of surgery and adjuvant therapy. J. Clin. Oncol. 2003; 21: 272–273
   Web of Science ®Google Scholar
• Kirkwood K. S., Khitin L. M., Barwick K. W. Prognostic indicators for cancer. Gastric cancer. Surg. Oncol. Clin. N. Am. 1997; 6: 495–514
   PubMedGoogle Scholar
• Yasui W., Oue N., Aung P. P., Matsumura S., Shutoh M., Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005; 8: 86–94
   PubMedGoogle Scholar
• Chen C. N., Lin J. J., Chen J. J., Lee P. H., Yang C. Y., Kuo M. L., Chang K. J., Hsieh F. J. Gene expression profile predicts patient survival of gastric cancer after surgical resection. J. Clin. Oncol. 2005; 23: 7286–7295
   PubMed Web of Science ®Google Scholar
• Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M. J., Sauter G., Kallioniemi O. P. Tissue microarrays for high-throughput molecular profiling of tumour specimens. Nature Med. 1998; 4: 844–847
   PubMed Web of Science ®Google Scholar
• Lee H. S., Lee H. K., Kim H. S., Yang H. K., Kim W. H. Tumour suppressor gene expression correlates with gastric cancer prognosis. J. Pathol. 2003; 200: 39–46
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. AJCC Cancer Staging Manual, Ed. 6. Lippincott-Raven, Philadelphia 2002
   Google Scholar
• Lee H. S., Chang M. S., Yang H. K., Lee B. L., Kim W. H. Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin. Cancer Res. 2004; 10: 1698–1705
   PubMed Web of Science ®Google Scholar
• Liu X. P., Kawauchi S., Oga A., Suehiro Y., Tsushimi K., Tsushimi M., Sasaki K. Combined examination of p27Kip1, p21Waf1/Cip1 and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma. Histopathology 2001; 39: 603–610
   PubMed Web of Science ®Google Scholar
• Mohsin S. K., Zhang M., Clark G. M., Allred D. C. Maspin expression in invasive breast cancer: association with other prognostic factors. J. Pathol. 2003; 199: 432–435
   PubMed Web of Science ®Google Scholar
• Parker C., Whittaker P. A., Usmani B. A., Lakshmi M. S., Sherbet G. V. Induction of 18A2/mts1 gene expression and its effects on metastasis and cell cycle control. DNA Cell Biol. 1994; 13: 1021–1028
   PubMed Web of Science ®Google Scholar
• Davies M. P., Rudland P. S., Robertson L., Parry E. W., Jolicoeur P., Barraclough R. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 1996; 13: 1631–1637
   PubMed Web of Science ®Google Scholar
• Sherbet G. V., Lakshmi M. S. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res. 1998; 18: 2415–2422
   PubMed Web of Science ®Google Scholar
• Rudland P. S., Platt-Higgins A., Renshaw C., West C. R., Winstanley J. H., Robertson L., Barraclough R. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res. 2000; 60: 1595–1603
   PubMed Web of Science ®Google Scholar
• Yonemura Y., Endou Y., Kimura K., Fushida S., Bandou E., Taniguchi K., Kinoshita K., Ninomiya I., Sugiyama K., Heizmann C. W., Schafer B. W., Sasaki T. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin. Cancer Res. 2000; 6: 4234–4242
   Google Scholar
• Helfman D. M., Kim E. J., Lukanidin E., Grigorian M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br. J. Cancer 2005; 92: 1955–1958
   PubMed Web of Science ®Google Scholar
• Flatmark K., Pedersen K. B., Nesland J. M., Rasmussen H., Aamodt G., Mikalsen S. O., Bjornland K., Fodstad O., Maelandsmo G. M. Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. J. Pathol. 2003; 200: 589–595
   PubMed Web of Science ®Google Scholar
• Cho Y. G., Nam S. W., Kim T. Y., Kim Y. S., Kim C. J., Park J. Y., Lee J. H., Kim H. S., Lee J. W., Park C. H., Song Y. H., Lee S. H., Yoo N. J., Park W. S. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 2003; 111: 539–545
   PubMed Web of Science ®Google Scholar
• Kimura K., Endo Y., Yonemura Y., Heizmann C. W., Schafer B. W., Watanabe Y., Sasaki T. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int. J. Oncol. 2000; 16: 1125–1131
   Google Scholar
• Takenaga K., Nakanishi H., Wada K., Suzuki M., Matsuzaki O., Matsuura A., Endo H. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin. Cancer Res. 1997; 3: 2309–2316
   PubMed Web of Science ®Google Scholar
• Ninomiya I., Ohta T., Fushida S., Endo Y., Hashimoto T., Yagi M., Fujimura T., Nishimura G., Tani T., Shimizu K., Yonemura Y., Heizmann C. W., Schafer B. W., Sasaki T., Miwa K. Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int. J. Oncol. 2001; 18: 715–720
   PubMed Web of Science ®Google Scholar
• Davies B. R., O'Donnell M., Durkan G. C., Rudland P. S., Barraclough R., Neal D. E., Mellon J. K. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J. Pathol. 2002; 196: 292–299
   PubMed Web of Science ®Google Scholar
• Joypaul B. V., Hopwood D., Newman E L., Qureshi S., Grant A., Ogston S. A., Lane D. P., Cuschieri A. The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma. Br. J. Cancer 1994; 69: 943–946
   PubMed Web of Science ®Google Scholar
• Gabbert H. E., Muller W., Schneiders A., Meier S., Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995; 76: 720–726
   PubMed Web of Science ®Google Scholar
• Starzynska T., Bromley M., Ghosh A., Stern P. L. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br. J. Cancer 1992; 66: 558–562
   PubMed Web of Science ®Google Scholar
• Gomyo Y., Ikeda M., Osaki M., Tatebe S., Tsujitani S., Ikeguchi M., Kaibara N., Ito H. Expression of p21(waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 1997; 79: 2067–2072
   PubMed Web of Science ®Google Scholar
• Ichiyoshi Y., Oiwa H., Tomisaki S., Sakaguchi Y., Ohno S., Maehara Y., Sugimachi K. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer. Hepatogastroenterology 1997; 44: 546–553
   PubMed Web of Science ®Google Scholar
• Fondevila C., Metges J. P., Fuster J., Grau J. J., Palacin A., Castells A., Volant A., Pera M. p53 and VEGF expression are independent predictors of tumor recurrence and survival following curative resection of gastric cancer. Br. J. Cancer 2004; 90: 206–215
   PubMed Web of Science ®Google Scholar
• Parker C., Lakshmi M. S., Piura B., Sherbet G. V. Metastasis associated mts1 gene expression correlates with increased p53 detection in the B16 murine melanoma. DNA Cell Biol. 1994; 13: 343–351
   PubMed Web of Science ®Google Scholar
• Grigorian M., Andersen S., Tulchinsky E., Kriajevska M., Carlberg C., Kruse C., Cohn M., Ambartsumian N., Christensen A. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein : functional consequences of their interaction. J. Biol. Chem. 2001; 276: 22699–22708
   PubMed Web of Science ®Google Scholar
• Chen H., Fernig D. G., Rudland P. S., Sparks A., Wilkinson M. C., Barraclough R. Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem. Biophys. Res. Commun. 2001; 286: 1212–1217
   PubMed Web of Science ®Google Scholar
• Diez M., Medrano M. J., Gutierrez A., Lopez A., Muguerza J. M., Hernandez P., Lozano O., Noguerales F., Ruiz A., Granell J. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy. Anticancer Res. 2000; 20: 3929–3933
   Google Scholar